Rankings
▼
Calendar
BEAM Q3 2018 Earnings — Beam Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BEAM
Beam Therapeutics Inc.
$3B
Q3 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$6M
Operating Income
-$13M
Net Income
-$70M
EPS (Diluted)
$-1.99
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$10M
Stock-Based Comp.
$4M
← FY 2018
All Quarters
Q4 2018 →